These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30707776)

  • 1. Atenolol treatment for severe infantile hemangiomas: comparison with a propranolol group of our centre.
    Dakoutrou M; Alexopoulos A; Miligkos M; Georgiadou E; Kanaka-Gantenbein C; Kakourou T
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):e199-e200. PubMed ID: 30707776
    [No Abstract]   [Full Text] [Related]  

  • 2. Atenolol as an alternative to propranolol for the management of sleep disturbances in the treatment of infantile hemangiomas.
    Gumina ME; Yan AC
    Pediatr Dermatol; 2019 Jul; 36(4):556-557. PubMed ID: 30983047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study.
    Ábarzúa-Araya A; Navarrete-Dechent CP; Heusser F; Retamal J; Zegpi-Trueba MS
    J Am Acad Dermatol; 2014 Jun; 70(6):1045-9. PubMed ID: 24656727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atenolol: a promising alternative to propranolol for the treatment of hemangiomas.
    Raphaël MF; de Graaf M; Breugem CC; Pasmans SGMA; Breur JMPJ
    J Am Acad Dermatol; 2011 Aug; 65(2):420-421. PubMed ID: 21763565
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta blocker treatment for infantile hemangiomas.
    Rouhana HF; Fruge JH; Massengale WT
    Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol in the Treatment of Infantile Hemangiomas: A Meta-Analysis in Chinese Patients.
    Li LL; Yan L; Luo MX; Cai YX; Mi XB; Zhang TD
    Pediatr Dermatol; 2015; 32(5):e210-4. PubMed ID: 26060892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should propranolol be initiated for infantile hemangiomas: inpatient versus outpatient?
    Patel NJ; Bauman NM
    Laryngoscope; 2014 Jun; 124(6):1279-81. PubMed ID: 24347141
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of a modified outpatient model for using propranolol to treat infantile hemangiomas.
    Putterman E; Wan J; Streicher JL; Yan AC
    Pediatr Dermatol; 2019 Jul; 36(4):471-476. PubMed ID: 31120143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Perspectives: Propranolol for infantile hemangiomas.
    Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
    Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
    J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.
    Nieuwenhuis K; de Laat PC; Janmohamed SR; Madern GC; Oranje AP
    Pediatr Dermatol; 2013; 30(1):64-70. PubMed ID: 22958179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary experiences in treating infantile hemangioma with propranolol.
    Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
    Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol treatment of infantile hemangiomas does not negatively affect psychomotor development.
    Moyakine AV; Hermans DJ; Fuijkschot J; van der Vleuten CJ
    J Am Acad Dermatol; 2015 Aug; 73(2):341-2. PubMed ID: 26183988
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
    Moyakine AV; Herwegen B; van der Vleuten CJM
    J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
    Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
    Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.
    Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J
    Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile during initiation of propranolol for treatment of infantile haemangiomas in an ambulatory day-care hospitalization setting.
    Fogel I; Ollech A; Zvulunov A; Valdman-Greenshpon Y; Atar Snir V; Friedland R; Lapidoth M; Ben-Amitai D
    J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):2004-2009. PubMed ID: 29573481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe infantile haemangioma: complications and treatment.
    Heaton P; Kennedy C; Amin S
    J Paediatr Child Health; 2014 Apr; 50(4):325, 330. PubMed ID: 24698064
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.
    Ji Y; Chen S; Yang K; Zhang X; Zhou J; Li L; Xiang B; Qiu T; Dai S; Jiang X; Lu G; Qiu L; Kong F; Zhang Y
    JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):599-607. PubMed ID: 33856430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers.
    Martin K; Blei F; Chamlin SL; Chiu YE; Frieden IJ; Frommelt PC; Garzon MC; Kwon EK; MacLellan-Tobert S; Mancini AJ; Seefeldt M; Sidbury R; Siegel DH; Drolet BA; Boucek RJ
    Pediatr Dermatol; 2013; 30(1):155-9. PubMed ID: 23316721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.